Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma (Including Ocular Melanoma)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
The Tolerance,Pharmacokinetic Characteristics,Safety and Efficacy of ScTIL210 in the Treatment of Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
- Status
- RECRUITING
- Phase
- N/A
Atypical MOLes and Melanoma Early Detection Study (MoleMed)
- Status
- UNKNOWN
- Phase
- NA
Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate Sotigalimab (APX005M) in Subjects With Unresectable or Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Hydrochlorothiazide and Risk of Skin Cancer
- Status
- COMPLETED
- Phase
- N/A
National Cancer Institute "Cancer Moonshot Biobank"
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Substudy 02A: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents in Participants With Programmed Cell-death 1 (PD-1) Refractory Melanoma (MK-3475-02A/KEYMAKER-U02)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma Who Are Candidates for Neoadjuvant Therapy (MK-3475-02C/KEYMAKER-U02)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Individual Patient Compassionate Use of GX-I7
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Immune Related-adverse Events in Patients Receiving Immune Checkpoint Inhibitors
- Status
- UNKNOWN
- Phase
- N/A
Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE4
A Study of NIVO Plus IPI and Guadecitabine or NIVO Plus IPI in Melanoma and NSCLC Resistant to Anti-PD1/PDL1
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Surgery of Melanoma Metastases After Systemic Therapy
- Status
- WITHDRAWN
- Phase
- PHASE2
Intensive Medicines Monitoring Study of Toripalimab Monoclonal Injection (Tuoyi) .
- Status
- UNKNOWN
- Phase
- N/A
Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1